Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPB1 | P04792 | 3/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39472 | 0.88 | HPGD (0.78) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL3547648 | 0.86 | HSPB1 (0.64) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL1341961 | 0.86 | HSPB1 (0.75) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL28056476 | 0.86 | L3MBTL1 (0.81) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL1338743 | 0.86 | HSPB1 (0.60) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL31470009 | 0.84 | HSPB1 (0.68) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL3597295 | 0.82 | HSPB1 (0.59) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL28317468 | 0.82 | HSPB1 (0.72) | HSPB1L3MBTL1HPGDALDH1A1MAPT | |
| SCHEMBL27751259 | 0.82 | HPGD (0.53) | HSPB1L3MBTL1HPGDALDH1A1TDP1 | |
| SCHEMBL11406237 | 0.81 | HPGD (0.68) | HSPB1L3MBTL1HPGDALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114002297-A | Dopamine ion carrier, dopamine sensitive membrane containing same, dopamine probe and preparation method | 何成 | 2022-02-01 | — | — | CN | claimed |
| US-20050006237-A1 | Ion-selective solid-state polymeric membrane electrondes | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2005-01-13 | — | — | US | claimed |
| EP-1287345-A2 | ION-SELECTIVE SOLID-STATE POLYMERIC MEMBRANE ELECTRODES | MEDTRONIC, INC. (US) | 2003-03-05 | — | — | EP | claimed |
| WO-2001088520-A2 | ION-SELECTIVE SOLID-STATE POLYMERIC MEMBRANE ELECTRODES | MEDTRONIC, INC. (US) | 2001-11-22 | — | — | WO | claimed |
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2025-10-02 | — | — | US | disclosed |
| EP-4580489-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DexCom, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| CN-119730782-A | Apparatus and method for measuring concentration of target analyte in biological fluid in vivo | 德克斯康公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20240074682-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DEXCOM, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| WO-2024050124-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DEXCOM, INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| WO-1999002651-A1 | OPTICAL FIBERLESS SENSORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1999-01-21 | — | — | WO | disclosed |
| EP-0300364-B1 | CHLORIDE ION-SELECTIVE ELECTRODE | HITACHI, LTD. (JP) | 1992-09-30 | — | — | EP | disclosed |
| US-5116481-A | ANION-SELECTIVE, SENSITIVE FILM, ELECTRODE CONTAINING THE SAME AND THE USE THEREOF | HITACHI, LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| US-5112471-A | Polymer, a nitrophenyl ether plastizer, quaternary ammonium or phosphonium salt | HITACHI, LTD. (JP) | 1992-05-12 | — | — | US | disclosed |
| US-4936975-A | Chloride ion-selective electrode | HITACHI, LTD. (JP) | 1990-06-26 | — | — | US | disclosed |
| EP-0339613-A2 | Ion selective electrode | HITACHI, LTD. (JP) | 1989-11-02 | — | — | EP | disclosed |
| EP-0300364-A2 | Chloride ion-selective electrode | HITACHI, LTD. (JP) | 1989-01-25 | — | — | EP | disclosed |
| EP-0059884-B1 | BENZOFURANE DERIVATIVES, THEIR PREPARATION AND USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | HSPB1 3861/4885L3MBTL1 4601/4885HPGD 1901/4885 |
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | VHL, BRCA1, TERT | HSPB1 2560/4885L3MBTL1 517/4885HPGD 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.